MOTCS: A Cancer Subtype Classification and Key Biomarker Recognition Model Based on Multi-Omics Data Integration of Transformer
Open Access
- 10 May 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (10) , 4237
Abstract
Cancer, as a complex disease with high heterogeneity, is gradually shifting from standardization to individualization. Current research indicates that integrating multi-omics data, including genome, transcriptome, and epigenome, can more comprehensively reveal the molecular features of tumors, thereby providing a more reliable basis for subtype classification. It is worth noting that driver genes, as key factors directly involved in tumorigenesis and development, when combined with multi-omics data, improve model interpretability. We proposed a cancer subtype classification model named MOTCS, which consists of four key steps: (1) The extraction of driver gene features from existing databases and the execution of preliminary feature selection for non-driver genes in different omics data; (2) the use of the transformer encoder to conduct feature representation learning for non-driver gene features and driver gene features, respectively; (3) the non-driver gene feature embeddings and driver gene feature embeddings of each omics learned are concatenated and input into the MLP classifier to obtain the classification probabilities of each subtype. (4) By integrating the above features through view association discovery networks, cross-omics feature representations are learned so as to achieve effective classification. The results show that MOTCS outperformed existing methods across all four datasets and that the introduction of driver genes will enhance the classification performance of MOTCS. MOTCS achieved precise classification of cancer subtypes by mining the feature embeddings of driver genes and non-driver gene features.Keywords
Funding Information
- National Natural Science Foundation of China (62225109)
- National Natural Science Foundation of China (62473094)
- National Natural Science Foundation of China (62531007)
- Natural Science Foundation of Heilongjiang Province (LH2024F003)
- Fundamental Research Funds for the Central Universities (2572025JT05-02)
This publication has 49 references indexed in Scilit:
- Synthesis and biological evaluation of theranostic Trastuzumab–SN38 conjugate for Near-IR fluorescence imaging and targeted therapy of HER2+ breast cancerEuropean Journal of Medicinal Chemistry, 2023
- Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortalityClinical and Translational Medicine, 2022
- Oncogenic Signaling Pathways in The Cancer Genome AtlasCell, 2018
- A deep learning-based multi-model ensemble method for cancer predictionComputer Methods and Programs in Biomedicine, 2018
- The Molecular Taxonomy of Primary Prostate CancerCell, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Androgen receptor signaling in prostate cancerCancer and Metastasis Reviews, 2014
- The complete family of epidermal growth factor receptors and their ligands are co-ordinately expressed in breast cancerBreast Cancer Research and Treatment, 2009
- ErbB receptors and signaling pathways in cancerCurrent Opinion in Cell Biology, 2009
- Steroid hormone receptor signaling in tumorigenesisJournal of Cellular Biochemistry, 2005